CPDA-1 209 mg/70mL

CPDA-1 209 mg/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, essential for maintaining blood quality during storage.

CPDA-1 209 mg/70mL is primarily used to prevent blood clotting in stored blood components. It is commonly used in medical settings to ensure the viability of blood for transfusions. The solution helps maintain the integrity of red blood cells and other components during storage, making it a critical part of blood preservation protocols.

When administered intravenously, CPDA-1 209 mg/70mL works by binding calcium ions, which are necessary for the clotting process. This action helps to keep the blood in a liquid state, ensuring it remains viable for transfusion. The solution also provides nutrients that support the metabolic needs of blood cells during storage.

CPDA-1 209 mg/70mL should be handled with care to avoid contamination. It is important to follow proper storage guidelines to maintain its effectiveness. Always consult healthcare professionals for appropriate use and handling procedures.

CPDA-1 209 mg/70mL may interact with certain medications or substances that affect blood clotting. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Always follow medical advice regarding the use of this solution.